| Literature DB >> 29307615 |
Hee Jun Cho1, Jong-Tae Kim1, Seon-Jin Lee2, Yo Sep Hwang1, Sang Yoon Park1, Bo-Yeon Kim3, Jiyun Yoo4, Kwan Soo Hong5, Jeong-Ki Min6, Chul-Ho Lee7, Jong-Seok Lim8, Suk Ran Yoon1, Inpyo Choi1, Yong-Kyung Choe9, Hee Gu Lee10.
Abstract
Rho GTPases control a wide range of cellular processes, and their deregulation is associated with promotion of an aggressive and metastatic tumor phenotype in human cancers. Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays a key role in regulating the activity of Rho GTPases. However, the underlying mechanisms are still unclear. In this study, we show that protein phosphatase 1B (PPM1B) interacts with RhoGDI1 and functions as its phosphatase. Ectopic expression of PPM1B results in dephosphorylation of RhoGDI1 and, thereby, abates the activation of RhoA, Rac1 and CDC42 by epidermal growth factor (EGF). PPM1B overexpression in Hs578T and SKBR3 human breast cancer cells decreases their motility and invasiveness in vitro and cancer metastasis in vivo. In contrast, knockdown of PPM1B in MCF-7 and MDA-MB-468 human breast cancer cells that express endogenous PPM1B enhances EGF-induced RhoGDI1 phosphorylation, activation of Rho GTPases, and cancer cell migration and invasion. Knockdown of RhoA or Rac1 by siRNA reverses the enhanced cell migration seen after PP1MB depletion. Collectively, these results indicate that PPM1B negatively regulates cancer cell motility and invasiveness through dephosphorylating RhoGDI1.Entities:
Keywords: Cancer; Migration; PPM1B; Rho GTPases; RhoGDI1
Mesh:
Substances:
Year: 2018 PMID: 29307615 DOI: 10.1016/j.canlet.2018.01.002
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679